02186.HK 綠葉製藥 | LUYE PHARMA | 公司資料 - 股權變動概覽 - etnet 經濟通|香港新聞財經資訊和生活平台

日期	股東名稱	披露原因	買入／賣出涉及的股份數目	每股平均價	持有權益的股份數目	佔已發行股本(%)
27/05/2025	UBS Group AG	1402(S)	+24,838,597(S)		472,535,967(L) 475,354,334(S)	12.56 12.64
26/05/2025	UBS Group AG	1502(S)	-3,781,369(S)		463,519,141(L) 448,057,378(S)	12.32 11.91
23/05/2025	UBS Group AG	1306(L)	129,973,185(L)		471,276,913(L) 456,359,150(S)	12.53 12.13
20/05/2025	UBS Group AG	1306(L)	12,781,100(L)		462,166,213(L) 464,387,150(S)	12.29 12.35
19/05/2025	UBS Group AG	1305(L)	148,944,620(L)		474,250,103(L) 465,440,150(S)	12.61 12.37
16/05/2025	UBS Group AG	1305(L)	20,836,628(L)		463,523,580(L) 465,575,150(S)	12.32 12.38
15/05/2025	UBS Group AG	1306(L)	158,785,020(L)		463,494,079(L) 465,703,150(S)	12.32 12.38
13/05/2025	UBS Group AG	1305(L)	158,123,120(L)		484,289,585(L) 477,545,881(S)	12.87 12.70
12/05/2025	UBS Group AG	1306(L)	150,951,776(L)		473,142,041(L) 473,871,381(S)	12.58 12.60
07/05/2025	UBS Group AG	1305(L)	157,800,417(L)		469,676,353(L) 473,027,881(S)	12.49 12.57
05/05/2025	UBS Group AG	1306(L)	157,192,708(L)		468,837,056(L) 472,524,381(S)	12.46 12.56
28/04/2025	Luye Pharma Holdings Ltd.	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	Shorea LBG	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	LuYe Pharmaceutical Investment Co., Ltd.	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	刘殿波	1314(L)	+2,000,000(L)		1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	Luye Life Sciences Group Ltd	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	Nelumbo Investments Limited	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	Ginkgo (PTC) Limited	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
28/04/2025	LuYe Pharmaceutical International Co., Ltd.	1101(L)	+2,000,000(L)	HKD1.990(L)	1,246,108,703(L) 212,229,950(S)	33.13 5.64
22/04/2025	刘殿波	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Luye Life Sciences Group Ltd	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	LuYe Pharmaceutical International Co., Ltd.	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	LuYe Pharmaceutical Investment Co., Ltd.	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Nelumbo Investments Limited	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Ginkgo (PTC) Limited	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Luye Life Sciences Group Ltd	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Luye Pharma Holdings Ltd.	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	LuYe Pharmaceutical International Co., Ltd.	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Shorea LBG	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Shorea LBG	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Ginkgo (PTC) Limited	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Nelumbo Investments Limited	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	Luye Pharma Holdings Ltd.	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	刘殿波	1314(L)	17,088,000(L)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
22/04/2025	LuYe Pharmaceutical Investment Co., Ltd.	1203(L) 15012(S)	-17,088,000(L) -17,088,000(S)		1,244,108,703(L) 212,229,950(S)	33.07 5.64
21/04/2025	UBS Group AG	1305(L)	13,369,550(L)		465,328,456(L) 464,873,640(S)	12.37 12.36
16/04/2025	UBS Group AG	1305(L)	129,682,526(L)		456,669,828(L) 463,472,105(S)	12.14 12.32
15/04/2025	UBS Group AG	1306(L)	131,986,981(L)		456,832,580(L) 463,053,391(S)	12.14 12.31
14/04/2025	UBS Group AG	1305(L)	131,986,981(L)		463,682,824(L) 469,465,634(S)	12.33 12.48
11/04/2025	UBS Group AG	1306(L)	168,178,893(L)		464,031,557(L) 469,480,810(S)	12.34 12.48

1 2 3 4 5 6

備註：	(L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
	(S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
	(P) - 可供借出的股份
	即時報價更新時間為 03/06/2025 17:59
	港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站

經濟通
強化版MQ
強化版TQ
財曆
Mobile
Web

客務熱線︰(852) 2880 7004 客務郵箱︰cs@etnet.com.hk
關於我們 | 產品服務 | 廣告查詢 | 聯絡我們 | 私隱政策 | 使用條款 | 網站導航 | 有用連結 | RSS新聞

Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.

《經濟通》所刊的署名及／或不署名文章，相關內容屬作者個人意見，並不代表《經濟通》立場，《經濟通》所扮演的角色是提供一個自由言論平台。